ELTP Elite Pharmaceuticals, Inc.

Fundamentals / CIK 0001053369 / USD

Elite Pharmaceuticals, Inc. reported $144.8M in revenue and net income of $60.28M for the trailing twelve months ended September 30, 2026 (up 10.4% year over year), with a 43.7% gross margin and a 25.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELTP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$147.7M$73.85M$0-$21.33MFY 2017 Revenue: $9.64MFY 2017 Net Income: $3.81M2017FY 2018 Revenue: $7.46MFY 2018 Net Income: -$3.67M2018FY 2019 Revenue: $7.57MFY 2019 Net Income: -$9.28M2019FY 2020 Revenue: $17.99MFY 2020 Net Income: -$2.24M2020FY 2021 Revenue: $25.38MFY 2021 Net Income: $5.09M2021FY 2022 Revenue: $32.26MFY 2022 Net Income: $8.90M2022FY 2023 Revenue: $34.16MFY 2023 Net Income: $3.56M2023FY 2024 Revenue: $56.63MFY 2024 Net Income: $20.11M2024FY 2025 Revenue: $84.04MFY 2025 Net Income: -$4.31M2025FY 2026 Revenue: $148.9MFY 2026 Net Income: $44.87M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Revenue $148.9M $84.04M $56.63M $34.16M $32.26M $25.38M $17.99M $7.57M $7.46M $9.64M
Cost of Revenue $73.85M $43.96M $30.27M $17.56M $17.47M $13.51M $10.02M $4.70M $3.51M $5.90M
Gross Profit $75.02M $40.09M $26.36M $16.59M $14.80M $11.87M $7.98M $2.87M $3.95M $3.74M
Research & Development $5.74M $7.96M $6.88M $6.20M $4.05M $5.11M $5.53M $7.60M $9.62M $8.30M
Total Operating Expenses $25.91M $20.49M $15.57M $12.92M $9.72M $9.76M $10.26M $12.03M $13.00M $11.10M
Operating Income $49.11M $19.60M $10.79M $3.68M $5.07M $2.10M -$2.29M -$9.16M -$9.05M -$7.36M
EBITDA $50.18M $20.83M $12.11M $4.95M $6.28M $3.42M -$966K -$7.90M -$8.05M -$6.64M
Interest Income $208K $21K $21K $7.5K $126 $514 $12K $21K $18K $13K
Interest Expense $111K $128K $589K $1.11M $192K $260K $356K $369K $335K $238K
Income Before Tax $56.81M -$52K $463K $3.99M $6.30M $4.14M -$2.24M -$9.96M -$4.72M $1.94M
Income Tax Expense $11.94M $4.26M -$19.65M $424K -$1.74M -- -- -$676K -$1.05M -$1.87M
Net Income $44.87M -$4.31M $20.11M $3.56M $8.90M $5.09M -$2.24M -$9.28M -$3.67M $3.81M
Basic EPS $0.04 $0.00 $0.02 $0.00 $0.01 $0.01 $0.00 -$0.01 $0.00 $0.03
Diluted EPS $0.03 $0.00 $0.02 $0.00 $0.01 $0.00 $0.00 -$0.01 -$0.01 -$0.01
Basic Shares Outstanding 1.07B 1.07B 1.02B 1.01B 1.01B 943.0M 832.3M 814.2M 796.1M 838.7M
Diluted Shares Outstanding 1.14B 1.07B 1.02B 1.01B 1.01B 943.0M 993.3M 816.3M 798.2M 844.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $40.08M $32.36M $40.75M $31.59M $36.32M $40.21M $32.00M $14.36M
Cost of Revenue $24.09M $18.85M $19.98M $18.64M $22.25M $12.99M $14.70M $8.24M
Gross Profit $15.99M $13.51M $20.77M $12.95M $14.07M $27.23M $17.30M $6.12M
Research & Development $1.88M $2.03M $1.64M $1.04M $1.39M $1.67M $2.04M $1.79M
Total Operating Expenses $6.06M $5.98M $10.59M $3.94M $5.86M $5.53M $6.14M $5.02M
Operating Income $9.93M $7.53M $10.19M $9.01M $8.21M $21.70M $11.15M $1.10M
EBITDA $10.20M $7.78M $10.44M $9.28M $8.49M $21.98M $11.44M $1.41M
Interest Income $219K $166K $115K $84K $4.9K $4.5K $4.6K $5.1K
Interest Expense $27K $27K $27K $27K $28K $29K $29K $31K
Income Before Tax $19.74M $7.72M $20.85M $20.83M $15.69M -$564K $19.27M -$10.65M
Income Tax Expense $2.43M $1.81M $2.39M $2.24M $1.99M $5.32M $2.27M $239K
Net Income $17.32M $5.91M $18.46M $18.59M $13.70M -$5.88M $17.00M -$10.89M
Basic EPS $0.02 $0.01 -- $0.02 $0.01 -$0.01 -- -$0.01
Diluted EPS $0.01 $0.01 -- $0.01 $0.01 -$0.01 -- -$0.01
Basic Shares Outstanding 1.08B 1.08B -- 1.07B 1.07B 1.07B -- 1.07B
Diluted Shares Outstanding 1.12B 1.13B -- 1.14B 1.14B 1.07B -- 1.07B

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents $29.80M $11.32M $7.11M $7.83M $8.54M $3.19M $1.13M $2.28M $7.18M $10.59M
Cash & Short-Term Investments $29.80M $11.32M $7.11M $7.83M $8.54M $3.19M $1.13M $2.28M $7.18M $10.59M
Accounts Receivable, Net $59.72M $29.21M $19.45M $3.09M $3.06M $3.50M $4.11M $1.32M $676K $934K
Inventory $21.26M $16.24M $12.93M $9.55M $6.74M $5.01M $4.14M $4.52M $4.90M $6.42M
Total Current Assets $112.1M $57.74M $40.01M $21.51M $18.86M $12.19M $10.25M $8.86M $13.70M $18.41M
Property, Plant & Equipment, Net $10.18M $10.33M $10.18M $10.43M $5.95M $6.65M $7.23M $8.44M $8.99M $9.04M
Intangible Assets $4.79M $5.64M $6.34M $6.34M $6.63M $6.63M $6.63M $6.63M $7.71M $6.42M
Other Non-Current Assets -- -- -- -- -- -- $480K $468K $473K $440K
Total Non-Current Assets $26.18M $38.65M $43.64M $19.39M $16.29M $13.99M $14.71M $15.55M $17.18M $15.90M
Total Assets $138.3M $96.39M $83.65M $40.90M $35.15M $26.19M $24.96M $24.40M $30.88M $34.31M
Accounts Payable $6.05M $2.96M $2.71M $2.45M $1.43M $930K $1.58M $1.38M $1.66M $1.05M
Deferred Revenue (Current) -- $5.6K $13K $13K $13K $13K $180K $1.01M $1.01M $1.01M
Total Current Liabilities $17.39M $11.84M $13.05M $7.83M $6.69M $5.81M $8.64M $6.91M $5.11M $3.34M
Long-Term Debt -- -- -- -- $1.25M $1.47M $1.57M -- -- --
Deferred Revenue (Non-Current) -- -- $5.6K $19K $32K $46K $59K $239K $1.25M $2.27M
Other Non-Current Liabilities -- -- -- -- $39K $38K $35K $46K $41K $32K
Total Non-Current Liabilities $22.02M $31.03M $13.02M $4.10M $3.23M $4.23M $5.66M $6.10M $7.29M $5.30M
Total Liabilities $39.41M $42.87M $26.07M $11.94M $9.93M $10.04M $14.30M $13.01M $12.41M $8.65M
Total Debt (incl. Leases) $2.78M $3.64M $4.16M $2.2K $2.28M $1.70M $1.95M -- -- --
Common Stock $1.08M $1.07M $1.07M $1.01M $1.01M $1.01M $841K $825K $803K $928K
Retained Earnings -$75.83M -$120.7M -$116.4M -$136.5M -$140.1M -$149.0M -$154.0M -$151.8M -$142.5M -$138.9M
Total Stockholders' Equity $98.88M $53.52M $57.58M $28.96M $25.22M $16.15M $10.66M -$2.51M $4.57M $25.66M
Total Equity $98.88M $53.52M $57.58M $28.96M $25.22M $16.15M $10.66M -$2.51M $4.57M $25.66M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $34.86M $38.94M $29.80M $21.09M $26.62M $21.74M $11.32M $8.29M
Cash & Short-Term Investments $34.86M $38.94M $29.80M $21.09M $26.62M $21.74M $11.32M $8.29M
Accounts Receivable, Net $63.22M $50.44M $59.72M $48.53M $40.87M $36.22M $29.21M $18.45M
Inventory $22.52M $24.20M $21.26M $25.10M $18.16M $19.36M $16.24M $20.16M
Total Current Assets $120.7M $114.5M $112.1M $96.79M $85.79M $77.86M $57.74M $48.05M
Property, Plant & Equipment, Net $11.20M $10.74M $10.18M $10.04M $10.10M $10.27M $10.33M $9.86M
Intangible Assets $4.79M $4.79M $4.79M $5.64M $5.64M $5.64M $5.64M $7.24M
Total Non-Current Assets $23.55M $25.18M $26.18M $29.62M $31.45M $33.48M $38.65M $42.71M
Total Assets $144.3M $139.7M $138.3M $126.4M $117.2M $111.3M $96.39M $90.76M
Accounts Payable $3.10M $5.59M $6.05M $6.52M $3.42M $5.09M $2.96M $5.84M
Deferred Revenue (Current) -- -- -- -- -- $2.2K $5.6K $8.9K
Total Current Liabilities $18.15M $30.44M $17.39M $13.19M $10.67M $10.76M $11.84M $14.69M
Total Non-Current Liabilities $3.97M $4.40M $22.02M $32.91M $44.99M $52.89M $31.03M $39.62M
Total Liabilities $22.12M $34.84M $39.41M $46.10M $55.66M $63.66M $42.87M $54.31M
Total Debt (incl. Leases) $2.33M $2.56M $2.78M $3.00M $3.22M $3.43M $3.64M $3.84M
Common Stock $1.08M $1.08M $1.08M $1.07M $1.07M $1.07M $1.07M $1.07M
Retained Earnings -$52.60M -$69.92M -$75.83M -$94.29M -$112.9M -$126.6M -$120.7M -$137.7M
Total Stockholders' Equity $122.2M $104.8M $98.88M $80.31M $61.58M $47.68M $53.52M $36.45M
Total Equity $122.2M $104.8M $98.88M $80.31M $61.58M $47.68M $53.52M $36.45M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income $44.87M -$4.31M $20.11M $3.56M $8.90M $5.09M -$2.24M -$9.28M -$3.67M $3.81M
Depreciation & Amortization $1.07M $1.23M $1.32M $1.28M $1.21M $1.31M $1.32M $1.26M $996K $715K
Stock-Based Compensation $177K $228K $160K $39K $14K $13K $62K $136K $245K $358K
Change in Receivables -$31.56M -$9.90M -$16.60M -$37K $438K $610K -$2.79M -$546K $258K $596K
Change in Inventory -$5.02M -$3.31M -$3.38M -$2.81M -$1.73M -$870K $373K $382K $1.52M -$3.12M
Change in Payables $3.10M $243K $22K -- -- -- -- -- -- --
Operating Cash Flow $23.75M $7.46M -$3.24M $3.34M $6.51M $3.19M -$1.79M -$6.79M -$4.81M -$7.88M
Capital Expenditure -$926K -$1.63M -$810K -$5.74M -$499K -$330K -$35K -$19K -$181K -$1.10M
Free Cash Flow $22.82M $5.83M -$4.04M -$2.40M $6.01M $2.86M -$1.83M -$6.81M -$4.99M -$8.98M
Investing Cash Flow -$926K -$2.40M -$810K -$5.74M -$499K -$263K -$35K $331K -$275K -$1.10M
Common Stock Issued -- -- -- -- -- $42K $1.44M $2.06M $2.00M $7.59M
Financing Cash Flow -$4.32M -$826K $3.34M $1.70M -$667K -$870K $690K $1.57M $1.67M $8.07M
Net Change in Cash $18.50M $4.23M -$706K -$696K $5.34M $2.06M -$1.14M -$4.90M -$3.41M -$917K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $17.32M $5.91M $18.46M $18.59M $13.70M -$5.88M $17.00M -$10.89M
Depreciation & Amortization $272K $253K $252K $269K $275K $275K $290K $313K
Stock-Based Compensation $20K $28K $29K $45K $50K $52K $52K $71K
Change in Receivables -$12.97M $9.44M -$11.36M -$7.79M -$5.19M -$7.22M -$10.92M $3.03M
Change in Inventory $1.68M -$2.94M $3.84M -$6.93M $1.19M -$3.12M $3.92M -$5.99M
Change in Payables -$2.49M -$462K -$469K $3.10M -$1.66M $2.13M -$2.88M $3.86M
Operating Cash Flow -$3.07M $10.07M $9.15M -$5.28M $5.10M $14.78M $3.92M -$1.06M
Capital Expenditure -$732K -$809K -$398K -$206K -$103K -$218K -$754K $0
Free Cash Flow -$3.81M $9.26M $8.75M -$5.48M $5.00M $14.56M $3.16M -$1.06M
Investing Cash Flow -$732K -$809K -$398K -$206K -$103K -$218K -$754K $0
Financing Cash Flow -$266K -$115K -$42K -$34K -$116K -$4.13M -$137K -$193K
Net Change in Cash -$4.07M $9.15M $8.71M -$5.52M $4.88M $10.43M $3.03M -$1.26M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Gross Margin 50.4% 47.7% 46.5% 48.6% 45.9% 46.8% 44.3% 37.9% 52.9% 38.8%
Operating Margin 33.0% 23.3% 19.1% 10.8% 15.7% 8.3% -12.7% -121.0% -121.4% -76.3%
Net Profit Margin 30.1% -5.1% 35.5% 10.4% 27.6% 20.0% -12.5% -122.6% -49.2% 39.5%
Return on Equity (ROE) 45.4% -8.1% 34.9% 12.3% 35.3% 31.5% -21.0% -- -80.3% 14.9%
Return on Assets (ROA) 32.4% -4.5% 24.0% 8.7% 25.3% 19.4% -9.0% -38.0% -11.9% 11.1%
Current Ratio 6.45x 4.88x 3.07x 2.75x 2.82x 2.10x 1.19x 1.28x 2.68x 5.50x
Quick Ratio 5.22x 3.50x 2.08x 1.53x 1.81x 1.24x 0.71x 0.63x 1.72x 3.59x
Debt to Equity 0.03x 0.07x 0.07x 0.00x 0.09x 0.11x 0.18x -- -- --
Revenue Growth (YoY) +77.1% +48.4% +65.8% +5.9% +27.1% +41.0% +137.8% +1.5% -22.6% -22.9%
Gross Profit Growth (YoY) +87.2% +52.1% +58.8% +12.2% +24.7% +48.7% +178.2% -27.4% +5.6% -53.3%
Operating Income Growth (YoY) +150.6% +81.7% +193.5% -27.5% +140.9% -- -- -- -- --
Net Income Growth (YoY) -- -121.5% +464.6% -60.0% +74.9% -- -- -- -196.4% --
EPS Growth (YoY) -- -100.0% -- -100.0% 0.0% -- -- -- -100.0% --
Operating Cash Flow Growth (YoY) +218.5% -- -196.9% -48.7% +103.8% -- -- -- -- --
Free Cash Flow Growth (YoY) +291.4% -- -- -139.9% +109.8% -- -- -- -- --
5Y Revenue / Share Growth +415.6% +263.9% +499.9% +259.9% +177.8% +45.1% +154.9% -6.5% -3.9% +22.9%
10Y Revenue / Share Growth +648.2% +827.4% +461.1% +245.8% +241.3% -- -- -- -- --
5Y Net Income / Share Growth +675.1% -- -- -- +93.8% -- -130.5% -- -208.3% --
10Y Net Income / Share Growth -- -145.7% -- -17.5% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 43.7% 43.5% 50.4% 51.1% 52.7% 55.8% 47.7% 44.2%
Operating Margin 25.3% 24.8% 33.0% 35.7% 34.3% 35.5% 23.3% 17.4%
Net Profit Margin 41.6% 40.2% 30.1% 31.0% 11.3% -10.3% -5.1% -25.7%
Return on Equity (ROE) 49.3% 54.1% 45.4% 54.0% 22.6% -22.7% -8.1% -49.4%
Return on Assets (ROA) 41.8% 40.6% 32.4% 34.3% 11.9% -9.7% -4.5% -19.8%
Current Ratio 6.65x 3.76x 6.45x 7.34x 8.04x 7.23x 4.88x 3.27x
Quick Ratio 5.41x 2.97x 5.22x 5.44x 6.34x 5.44x 3.50x 1.90x
Debt to Equity 0.02x 0.02x 0.03x 0.04x 0.05x 0.07x 0.07x 0.11x
Revenue Growth (YoY) +10.4% -19.5% +27.4% +119.9% +92.4% +113.9% +78.3% -7.6%
Gross Profit Growth (YoY) +13.6% -50.4% +20.1% +111.7% +71.7% +221.3% +113.0% -13.1%
Operating Income Growth (YoY) +20.8% -65.3% -8.7% +721.0% +135.7% +461.6% +199.1% -68.9%
Net Income Growth (YoY) +26.4% -- +8.6% -- -- -1055.7% +411.1% -1642.0%
EPS Growth (YoY) +100.0% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -160.2% -31.8% +133.4% -- +250.4% +369.9% +86.6% --
Free Cash Flow Growth (YoY) -176.1% -36.4% +176.5% -- +266.5% +515.3% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001053369) · from September 30, 2010 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal